Davies Mark J, Lomas David A
Department of Medicine, University of Cambridge, Cambridge Institute for Medical Research, Wellcome Trust/MRC Building, Hills Road, Cambridge CB2 0XY, United Kingdom.
Int J Biochem Cell Biol. 2008;40(6-7):1273-86. doi: 10.1016/j.biocel.2007.12.017. Epub 2008 Jan 17.
Members of the serine proteinase inhibitor or serpin superfamily inhibit their target proteinases by a conformational transition that involves the enzyme being translocated from the upper to the lower pole of the protein. This sophisticated mechanism is subverted by point mutations to form ordered polymers that are retained within the endoplasmic reticulum of the cell of synthesis. These polymers activate NF-kappaB and cause cytotoxicity by a pathway that is independent of the unfolded protein response. As diverse conditions can be explained the same mechanism of polymerisation we have grouped them together as a new class of disease, the serpinopathies. We review here the structural basis of the serpinopathies and discuss how the ordered accumulation of polymers causes cell death.
丝氨酸蛋白酶抑制剂家族(serpin超家族)的成员通过一种构象转变来抑制其靶蛋白酶,这种转变涉及酶从蛋白质的上极转移到下极。这种复杂的机制会因点突变而被破坏,从而形成有序聚合物,这些聚合物保留在合成细胞的内质网中。这些聚合物激活核因子κB,并通过一条独立于未折叠蛋白反应的途径引起细胞毒性。由于多种情况都可以用相同的聚合机制来解释,我们将它们归为一类新的疾病——丝氨酸蛋白酶抑制剂病。我们在此回顾丝氨酸蛋白酶抑制剂病的结构基础,并讨论聚合物的有序积累如何导致细胞死亡。